Source: Eur Respir J 2007; 29: 156-178
Disease area: Pulmonary vascular diseases, Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
McNicholas W. T., Bonsignore M. R., on behalf of the .... Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 2007; 29: 156-178

Member's Comments

No comment yet.

Related content which might interest you: Is obstructive sleep apnoea a risk factor for cardiovascular disease? Source: Annual Congress 2005 - Cardiovascular disease and obstructive sleep apnoea: risks and remedy Year: 2005 Obstructive sleep apnea syndrome is an independent risk factor for progression of chronic kidney disease: A new link? Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease Year: 2010 Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation Source: Eur Respir J 2009; 33: 1195-1205 Year: 2009 Understanding the pathophysiological mechanisms of cardiometabolic complications in obstructive sleep apnoea: towards personalised treatment approaches Source: Eur Respir J, 56 (2) 1902295; 10.1183/13993003.02295-2019 Year: 2020 Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008 Physical activity: the key to cardiometabolic risk reduction in obstructive sleep apnoea Source: Eur Respir J, 52 (4) 1801775; 10.1183/13993003.01775-2018 Year: 2018 Combination between sleep apnoea and COPD: a synergistic risk for cardiovascular diseases? Source: Sleep and Breathing Conference 2017 Year: 2017 Genetic determinants of cardiovascular disease in patients with obstructive sleep apnea (OSA) Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing Year: 2015 Gender differences in global cardiovascular risk factors of obstructive sleep apnea patients Source: Eur Respir J 2006; 28: Suppl. 50, 413s Year: 2006 Treatment of obstructive and central sleep apnoea in heart failure: current concepts and perspectives Source: Annual Congress 2005 - PG12 - Sleep-related problems: treatment of obstructive sleep apnoea - current concepts and perspectives Year: 2005 Diet and exercise in the management of obstructive sleep apnoea and cardiovascular disease risk Source: Eur Respir Rev, 26 (144) 160110; 10.1183/16000617.0110-2016 Year: 2017 Obstructive pulmonary disorder is a potential risk factor of cardiovascular diseases in obstructive sleep apnea Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep Year: 2008 Obesity, sleep apnoea and COVID-19: relationship, risk and therapeutic implications Source: Sleep and Breathing Conference 2021 Year: 2021 Physical activity in obstructive sleep apnea (OSA) patients with high cardiovascular risk Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise Year: 2010 Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment Source: Eur Respir J 2002; 20: 1511-1518 Year: 2002 Obstructive sleep apnoea and COPD Source: Eur Respir Mon 2013; 59: 135-143 Year: 2013 The risk of future cardiovascular diseases in the patients with OSAS is dependently or independently associated with obstructive sleep apnoea Source: Eur Respir J 2001; 17: 573-574 Year: 2001 Smoking (active and former) among factors influencing severity of both pathologies in a population with obstructive sleep apnea (OSA) and chronic obstructive bronhopneumopathy (COPD) Source: Annual Congress 2010 - Smoking related diseases, damages due to environmental tobacco smoke and smoking control strategies Year: 2010 Treatment of obstructive and central sleep apnoea in heart failure: practical options Source: Eur Respir Rev 2007; 16: 183-188 Year: 2007